Mitoxantrone,  a multiple sclerosis (MS)  drug that is already associated with a higher risk for leukemia and heart damage, may also raise a person’s risk of colorectal cancer, researchers at the University of Würzburg, in Germany, reported. If confirmed in larger studies, the findings indicate that colonoscopies should be conducted on MS patients after…
mitoxantrone
New research from Italy and Spain demonstrated that intense immunosuppression followed by autologous hematopoietic stem cell transplantation (AHSCT) was better than the medication mitoxantrone in treating severe cases of multiple sclerosis. The study appeared in the February 11, 2015, online issue of Neurology.  MS is characterized by an immune system attack on the…
Recommended Posts
- Fenebrutinib again bests Aubagio in trial at cutting MS relapse rates
- I don’t have to be an Olympic medalist to achieve remarkable things
- New study links specific MRI lesion pattern to MS risk before symptoms
- With MS, parenting a teenager can get a little bloody — for dad
- Foralumab reduces microglial activity, inflammation in nonactive SPMS